Advertisement

Topics

Mylan Gets FDA's Tentative Approval For 'TLD' Under PEPFAR For HIV/AIDS

08:27 EDT 7 Aug 2017 | FinanzNachrichten

CANONSBURG (dpa-AFX) - Mylan N.V. (MYL) announced Monday the receipt of tentative approval from the U.S. Food and Drug Administration under the U.S. President's Emergency Plan for AIDS Relief or P...

Original Article: Mylan Gets FDA's Tentative Approval For 'TLD' Under PEPFAR For HIV/AIDS

NEXT ARTICLE

More From BioPortfolio on "Mylan Gets FDA's Tentative Approval For 'TLD' Under PEPFAR For HIV/AIDS"

Quick Search
Advertisement